{
  "ticker": "REGN",
  "year": 2024,
  "quarter": 2,
  "last_updated": "2025-04-19T07:36:40.944791",
  "count": 13,
  "transactions": [
    {
      "id": 44627,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-05-21",
      "transaction_shares": "1865",
      "transaction_price": "994.9",
      "transaction_type": "S",
      "shares_after_transaction": "34678"
    },
    {
      "id": 44632,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-17",
      "transaction_shares": "22687",
      "transaction_price": "979.22",
      "transaction_type": "S",
      "shares_after_transaction": "467020"
    },
    {
      "id": 44615,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-16",
      "transaction_shares": "907",
      "transaction_price": "967.4",
      "transaction_type": "S",
      "shares_after_transaction": "835476"
    },
    {
      "id": 44611,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "111",
      "transaction_price": "965.69",
      "transaction_type": "S",
      "shares_after_transaction": "886272"
    },
    {
      "id": 44636,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-13",
      "transaction_shares": "203204",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "577633"
    },
    {
      "id": 44609,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "2000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "28349"
    },
    {
      "id": 44631,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-05-01",
      "transaction_shares": "250",
      "transaction_price": "889.41",
      "transaction_type": "S",
      "shares_after_transaction": "12931"
    },
    {
      "id": 44635,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "3",
      "transaction_price": "889.5",
      "transaction_type": "S",
      "shares_after_transaction": "18179"
    },
    {
      "id": 44628,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-04-29",
      "transaction_shares": "36296",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 27642,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-04-01",
      "transaction_shares": "250",
      "transaction_price": "964.73",
      "transaction_type": "S",
      "shares_after_transaction": "13181"
    },
    {
      "id": 27658,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-01",
      "transaction_shares": "2",
      "transaction_price": "957.78",
      "transaction_type": "S",
      "shares_after_transaction": "18280"
    },
    {
      "id": 44613,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-04-01",
      "transaction_shares": "250",
      "transaction_price": "964.73",
      "transaction_type": "S",
      "shares_after_transaction": "13181"
    },
    {
      "id": 44634,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-01",
      "transaction_shares": "2",
      "transaction_price": "957.78",
      "transaction_type": "S",
      "shares_after_transaction": "18280"
    }
  ]
}